Source: EClinicalMedicine. Unidade: FMRP
Subjects: VACINAS, IMUNOGENICIDADE DA VACINA, HPV, HIV
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOLSCHWEILLER, Nicolas et al. Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: a phase IV randomized comparative study. EClinicalMedicine, v. 23, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.eclinm.2020.100353. Acesso em: 04 nov. 2024.APA
Folschweiller, N., Teixeira, J. C., Joshi, S., Goldani, L. Z., Supparatpinyo, K., Basu, P., et al. (2020). Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: a phase IV randomized comparative study. EClinicalMedicine, 23. doi:10.1016/j.eclinm.2020.100353NLM
Folschweiller N, Teixeira JC, Joshi S, Goldani LZ, Supparatpinyo K, Basu P, Chotpitayasunondh T, Chetchotisakd P, Ruxrungtham K, Roteli-Martins C, Grinsztejn B, Quintana SM, Kumarasamy N, Poongulali S, Kulkarni V, Lin L, Datta SK, Descamps D, Dodet M, Dubin G, Friel D, Hezareh M, Karkada N, Camilleri DM, Poncelet S, Salaun B, Silva FT da, Thomas-Jooris F, Struyf F. Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: a phase IV randomized comparative study [Internet]. EClinicalMedicine. 2020 ; 23[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.eclinm.2020.100353Vancouver
Folschweiller N, Teixeira JC, Joshi S, Goldani LZ, Supparatpinyo K, Basu P, Chotpitayasunondh T, Chetchotisakd P, Ruxrungtham K, Roteli-Martins C, Grinsztejn B, Quintana SM, Kumarasamy N, Poongulali S, Kulkarni V, Lin L, Datta SK, Descamps D, Dodet M, Dubin G, Friel D, Hezareh M, Karkada N, Camilleri DM, Poncelet S, Salaun B, Silva FT da, Thomas-Jooris F, Struyf F. Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: a phase IV randomized comparative study [Internet]. EClinicalMedicine. 2020 ; 23[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.eclinm.2020.100353
